Friday, March 4, 2016

A Troubling Timeline at Valeant by GRETCHEN MORGENSON


By GRETCHEN MORGENSON

A growing trickle of head-scratching news adds to gaps in Valeant Pharmaceuticals’ financial disclosures, despite attempts to burnish results.

Published: March 6, 2016 at 12:00AM

from NYT Business Day http://ift.tt/21Kza12



from WordPress http://ift.tt/1oVEwET
via Hadi Aboukhater
Posted by at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)